§ 203.10. Restrictions on reimportation.
65 words·~1 min read·
/us/cfr/t21/s§ 203.10·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
No prescription drug or drug composed wholly or partly of insulin that was manufactured in a State and exported from the United States may be reimported by anyone other than its manufacturer, except that FDA may grant permission to a person other than the manufacturer to reimport a prescription drug or insulin-containing drug if it determines that such reimportation is required for emergency medical care.